Clinical Trial Update: Residual Exacerbations With Mepolizumab

View source ↗

Summary

A Laval University–sponsored study is evaluating residual exacerbations in asthma patients treated with mepolizumab and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Mepolizumab (mepolizumab)

Snippet

Sponsor: Laval University | Conditions: Asthma | Status: RECRUITING